Question 1

What is the capital ask and investment ticket?

Accepted Answer

A single clean capital ask covers the full 130-bed specialised tertiary hospital. We are open to co-investment where multiple parties combine, but our preferred structure is a single anchor investor or a small club of 2-3 institutional partners. Smaller minority positions are possible by negotiation. Full capital ask and use-of-funds breakdown available to qualified investors on inquiry.

Question 2

Is the structure equity, debt or both?

Accepted Answer

Open. We have not pre-specified the capital structure. The investor proposes — equity, senior debt, mezzanine, convertible, blended, or joint venture. The project economics work across multiple structures, and we adapt to the partner's mandate. The financial model shared under NDA is unlevered (no debt assumption) so you can layer in your preferred capital stack.

Question 3

How do you handle currency risk?

Accepted Answer

Botswana Pula is one of Africa's most stable currencies. Medical equipment contracts and reference patient pricing can be denominated in hard currency by agreement. Full currency, FX and capital-flow framework details are shared with qualified investors on inquiry.

Question 4

What is the SSKIA SEZ footing worth to the project?

Accepted Answer

Materially significant for project economics. The full fiscal architecture and its quantified impact on the 25-year model are shared with qualified investors on inquiry under NDA.

Question 5

Who owns the land?

Accepted Answer

The project site is allocated within the Sir Seretse Khama International Airport Special Economic Zone, governed by SEZA. Tenure is long-term leasehold aligned to the SEZA framework. Ownership, tenure and transferability mechanics are shared with qualified investors on inquiry.

Question 6

What is the exit strategy?

Accepted Answer

Several exit pathways are contemplated for the partnership. The specific exit architecture, transferability and liquidity mechanics are discussed with qualified investors on inquiry and agreed at partnership formation.

Question 7

How conservative is the financial model?

Accepted Answer

The model uses conservative assumptions: an initial ~35% Year 1 occupancy ramping over three years to steady state, stabilised EBITDA margins below international tertiary hospital benchmarks, no significant medical tourism upside in the base case, and a hurdle-rate assumption above typical infrastructure benchmarks. Upside scenarios are documented but not relied upon. Detailed assumptions log available under NDA.

Question 8

What about clinical staffing in a small market?

Accepted Answer

Clinical operations partnership with Advance Medical Africa provides protocols, staffing pipelines and training integration. SADC region clinical recruitment plan in place. Several specialists already committed to the project on conditional letters of intent. Botswana has produced specialists who are returning home for the right opportunity — TEMCO is that opportunity.

Question 9

Why opening in 2029, not earlier?

Accepted Answer

Realistic delivery: capital formation 2026, construction Q4 2026 to Q1 2029, commissioning Q1 2029, operations Q2 2029. That is a 24-month build for a 130-bed specialised tertiary facility — the international benchmark for this scope. Compressing the timeline introduces execution risk that we are not willing to take with investor capital.

Question 10

What if the project doesn't hit its numbers?

Accepted Answer

Downside scenarios are modelled in detail with significant headroom before breakeven and with the project remaining cash-flow positive under conservative revenue stress testing. The hospital is a tangible asset — even in a stress scenario, the underlying real estate and clinical infrastructure retain significant residual value. We do not promise outcomes; we share modelled scenarios with qualified investors under NDA and let them form their own view.

News & Updates

Investor Memorandum Released

Advance Medical Africa Confirmed as Clinical Operations Partner

PEMANDU MTM Designation Confirmed

Clinical Advisory Team Expanded

SEZA Qualifying Status Granted

Pre-Operational Project Team Finalised

Stay Informed